Dopamine agonist therapy for hyperprolactinemia.
Bankowski
Brandon J
BJ
Department of Obstetrics and Gynecology, Johns Hopkins Medical Instituttions, Baltimore, MD 21210, USA.
Zacur
Howard A
HA
D000634:Aminoquinolines / Q000627:therapeutic use; D052160:Benzothiazoles; D001971:Bromocriptine / Q000627:therapeutic use; D000077465:Cabergoline; D002986:Clinical Trials as Topic; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004873:Ergolines / Q000627:therapeutic use; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy*; D007211:Indoles / Q000627:therapeutic use; D010479:Pergolide / Q000627:therapeutic use; D000077487:Pramipexole; D013844:Thiazoles / Q000627:therapeutic use
D000634:Aminoquinolines; D052160:Benzothiazoles; D018491:Dopamine Agonists; D004873:Ergolines; D007211:Indoles; D013844:Thiazoles; C046649:ropinirole; D010479:Pergolide; D001971:Bromocriptine; D004877:Ergoloid Mesylates; C046650:quinagolide; D000077487:Pramipexole; D000077465:Cabergoline